Smith, Moore & Co’s Gossamer Bio GOSS Stock Holding History

Smith, Moore & Co’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$148K	Buy	900,000 +430,000	+91%	+$120K	0.01%	571
2026 Q1	$154K	Buy	470,000 +190,000	+68%	+$299K	0.01%	540
2025 Q4	$868K	Hold	280,000	–	–	0.07%	225
2025 Q3	$736K	Sell	280,000 -20,000	-7%	-$44.1K	0.06%	256
2025 Q2	$369K	Hold	300,000	–	–	0.03%	351
2025 Q1	$330K	Hold	300,000	–	–	0.03%	358
2024 Q4	$271K	Buy	300,000 +74,000	+33%	+$63.4K	0.02%	391
2024 Q3	$223K	Hold	226,000	–	–	0.02%	420
2024 Q2	$204K	Buy	226,000 +100,000	+79%	+$74.8K	0.02%	426
2024 Q1	$149K	Hold	126,000	–	–	0.02%	417
2023 Q4	$115K	Buy	126,000 +60,000	+91%	+$44.3K	0.01%	402
2023 Q3	$55K	Hold	66,000	–	–	0.01%	378
2023 Q2	$79.2K	Hold	66,000	–	–	0.01%	389
2023 Q1	$83.2K	Buy	66,000 +41,000	+164%	+$78.5K	0.01%	378
2022 Q4	$54.3K	Buy	25,000 +10,000	+67%	+$82.3K	0.01%	371
2022 Q3	$180K	Buy	+15,000	New	+$186K	0.03%	352
2022 Q2	–	Sell	-19,500	Closed	-$169K	–	405
2022 Q1	$169K	Hold	19,500	–	–	0.02%	397
2021 Q4	$221K	Buy	19,500 +9,500	+95%	+$113K	0.03%	375
2021 Q3	$126K	Buy	+10,000	New	+$92.1K	0.02%	406

Other funds holding GOSS

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

DIG

DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

Smith, Moore & Co's GOSS Position: Q2 2026 in Review

Smith, Moore & Co increased its Gossamer Bio (GOSS) stake by 91% in Q2 2026, buying an estimated $120K and bringing the position to 900,000 shares worth $148K. The position accounts for 0.01% of the portfolio, ranked #571.

Smith, Moore & Co first reported a position in GOSS in Q3 2021 and has held it in 19 quarters since. The position peaked at $868K in Q4 2025. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

Smith, Moore & Co held 900,000 shares of Gossamer Bio worth $148K as of Q2 2026.
Smith, Moore & Co bought 430,000 Gossamer Bio shares in Q2 2026, an estimated $120K.
Gossamer Bio made up 0.01% of Smith, Moore & Co's portfolio in Q2 2026, its #571 holding.
Smith, Moore & Co first reported a position in Gossamer Bio in Q3 2021 and has held it in 19 quarters since.
Smith, Moore & Co's Gossamer Bio position peaked at $868K in Q4 2025.
170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Smith, Moore & Co's 13F filing for Q2 2026, filed 12 Aug 2026.